Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
Immunomedics Inc
(NQ:
IMMU
)
87.86
USD
UNCHANGED
Last Price
Updated: 7:41 PM EDT, Oct 22, 2020
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Stories about Immunomedics Inc
< Previous
1
2
3
4
5
6
7
8
9
...
27
28
Next >
Should Investors Consider This Biotech Takeover Target?
December 21, 2020
Getting in on the extensive merger and acquisition game of large pharmaceutical companies is the ultimate endgame for Exelixis, a biotech that already boasts an established cancer-focused product...
Tags
MNTA
NVS
LLY
From
Motley Fool
Gilead's New CEO Is Going All-In on Acquisitions
November 28, 2020
Daniel O'Day has made increasingly larger deals in an effort to improve the company's portfolio of cancer drugs.
Tags
Market News
IMMU
GLPG
From
Motley Fool
Week In Review: Three $300 Million Deals For China Biopharma
November 07, 2020
China Grand Pharma announced a $340 million agreement to develop and commercialize Telix Pharma's molecularly-targeted radiation products in China. China Grand Pharma will make a $25 million upfront...
Tags
Pharma/Biotech
Stocks / Equities
From
Blogs - TalkMarkets
Everest Medicines Starts China Trial of Triple-Negative Breast Cancer ADC
November 06, 2020
Everest Medicines has dosed the first patient in a registrational China Phase IIb trial of Trodelvy TM to treat metastatic triple-negative breast cancer. Trodelvy (sacituzumab govitecan) is a...
From
ChinaBio® Today
The Daily Biotech Pulse: Gilead Gets Full Approval For Remdesivir, Akebia's Positive Readout, Foghorn IPO
October 23, 2020
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ...
Tags
PRAX
RGEN
Market News
From
Benzinga
Gilead Sciences Gets FDA Approval For Covid-19 Treatment Remdesivir
October 22, 2020
Gilead Sciences got FDA approval for its Covid-19 treatment that already had emergency authorization, remdesivir, sending GILD stock up after hours on the day shares touched a seven-year low.
From
Investor's Business Daily
Stocks That Hit 52-Week Highs On Thursday
October 22, 2020
During Thursday's morning session, 66 stocks hit new 52-week highs. Interesting Facts: Thermo Fisher Scientific ...
Tags
BCOV
Penny Stocks
Benzinga
From
Benzinga
Noteworthy ETF Outflows: XBI, IMMU, ARWR, BPMC
October 22, 2020
Symbols mentioned in this story: XBI, IMMU, ARWR, BPMC Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These...
Tags
ETFs
From
ETF Channel
The Daily Biotech Pulse: FDA Vaccine Committee Meeting, Roche In $350M Deal for COVID-19 Treatment, Edwards Lifesciences Reports Q3 Beat
October 22, 2020
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...
Tags
Biotech
RHHBY
JNJ
From
Benzinga
Stocks That Hit 52-Week Highs On Wednesday
October 21, 2020
Before 10 a.m. ET on Wednesday, 74 companies hit new 52-week highs. Noteables: The largest company on a market cap ...
Tags
KKR
PINS
Information Technology
From
Benzinga
The Daily Biotech Pulse: Prothena Progress In Parkinson's Disease Pipeline, Fast Track For Xeris, Biogen Earnings
October 21, 2020
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ...
Tags
BPMC
IBB
Offerings
From
Benzinga
Stocks That Hit 52-Week Highs On Tuesday
October 20, 2020
Tuesday's morning session saw 59 companies set new 52-week highs. Areas of Significance: MercadoLibre (NASDAQ: ...
Tags
CVET
SRAC
Market News
From
Benzinga
The Daily Biotech Pulse: Aptinyx Jumps On Positive Readout, Cara Executes Korsuva Licensing Deal, Cleveland BioLabs Rallies On Reverse Merger
October 20, 2020
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...
Tags
PRQR
ZSAN
APTX
From
Benzinga
Stocks That Hit 52-Week Highs On Monday
October 19, 2020
During Monday's morning trading, 115 companies set new 52-week highs. Intriguing Points: The largest company on a ...
Tags
TGH
CAI
52 Week Highs
From
Benzinga
Stocks That Hit 52-Week Highs On Friday
October 16, 2020
Before 10 a.m. ET on Friday, 168 companies set new 52-week highs. Noteworthy Points: The largest company on a market ...
Tags
BBY
CSWI
HUM
From
Benzinga
The Daily Biotech Pulse: Vertex Pulls Plug On Protein Deficiency Drug, FDA Nod For Regeneron's Ebola Treatment, Can Fite Issues Psoriasis Readout
October 15, 2020
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...
Tags
CRSP
IMMU
REPL
From
Benzinga
Stocks That Hit 52-Week Highs On Wednesday
October 14, 2020
During Wednesday's morning session, 143 companies made new 52-week highs. Points of Interest: The largest company ...
Tags
PAYC
MYRG
FIVN
From
Benzinga
If You Invested $1,000 in Gilead Sciences' IPO, This Is How Much Money You'd Have Now
October 11, 2020
Gilead's stock has been volatile, but if you had bought it early, right after its IPO in 1992, you would have done quite well.
Tags
IMMU
Market News
GILD
From
Motley Fool
Is Gilead Sciences a Buy?
October 11, 2020
Investors interested in Gilead Sciences need to look forward, not backward, to avoid the common trap of thinking history will repeat itself.
Tags
ABBV
IMMU
Market News
From
Motley Fool
Noteworthy ETF Outflows: XBI, IMMU, SRNE, BPMC
October 06, 2020
Symbols mentioned in this story: XBI, IMMU, SRNE, BPMC Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These...
Tags
ETFs
From
ETF Channel
Notable ETF Inflow Detected - XBI, IMMU, SRNE, INO
September 28, 2020
Symbols mentioned in this story: XBI, IMMU, SRNE, INO Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These ''units''...
Tags
ETFs
From
ETF Channel
The Daily Biotech Pulse: Gilead's $7.25B Debt Offering, Lexicon Deleverages, Taysha Gene Therapies Prices IPO
September 24, 2020
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...
Tags
OSUR
NRBO
BLU
From
Benzinga
The Week Ahead In Biotech: Conference Presentations, IPOs In The Mix
September 20, 2020
Biotech stocks found themselves among gains in the week ended Sept. 18, with conference presentations, IPO news flow and updates on ...
Tags
IMMU
Market News
Top Stories
From
Benzinga
Cytodyn's Update Provides A Clear Path Towards Approval With Up-Listing Potential Still In The Cards
September 18, 2020
This is to clarify the recent conference call and counter misleading information on it by shorters etc.
Tags
Stocks / Equities
Pharma/Biotech
From
Blogs - TalkMarkets
XBI, IMMU, NVAX, NVTA: ETF Outflow Alert
September 18, 2020
Symbols mentioned in this story: XBI, IMMU, NVAX, NVTA Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These...
Tags
ETFs
From
ETF Channel
ETF Wrap: How to think about – and play – the wave of M&A activity
September 17, 2020
ETF Wrap is a briefing of what investors need to know in the exchange-traded sector, including exclusive commentary and interviews on the industry from MarketWatch
Tags
IMMU
VO
MS
From
MarketWatch
M&A ETFs Sizzling on Recent Deal Activities
September 16, 2020
Here are a few merger ETFs to ride out the surge from the increasing M&A deals. Any of these could make compelling options for investors seeking to implement this low correlation strategy to their...
Tags
ETFs
From
Blogs - TalkMarkets
The M&A surge: Is it rational exuberance or a frenzy before the market falls?
September 15, 2020
Global mergers and acquisitions volumes have reached $1.97 trillion so far this year.
Tags
Telecommunications
M&A
Company Announcements/Warnings
From
MarketWatch
Benzinga's Top Upgrades, Downgrades For September 15, 2020
September 15, 2020
Upgrades DA Davidson upgraded the previous rating for Hancock Whitney Corp (NASDAQ: HWC) from Neutral to Buy. In the second ...
Tags
NNOX
LANC
Initiations
From
Benzinga
10 Biggest Price Target Changes For Tuesday
September 15, 2020
Raymond James raised Lennar Corporation (NYSE: LEN) price target from $75 to $90. Lennar shares fell 3.8% to $76.00 in pre-market ...
Tags
SGEN
PPD
TPX
From
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
27
28
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.